Showing 1 - 2 results of 2 for search 'J. M. M. Groenewoud', query time: 0.02s
Refine Results
-
1
Two-year follow-up of a dose reduction strategy trial of biologics adalimumab, etanercept, and ustekinumab in psoriasis patients in daily practice by S. Atalay, J. M. P. A. van den Reek, J. M. M. Groenewoud, P. C. M. van de Kerkhof, W. Kievit, E. M. G. J. de Jong
Published 2022-04-01
Article -
2
Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry by Lara S. van derSchoot, Hans J. M. M. Groenewoud, Marleen M. H. J. vanGelder, Marisol E. Otero, W. Peter Arnold, Maartje A. M. Berends, Marjolein S. De Bruin‐Weller, Sharon R. P. Dodemont, Marloes M. Kleinpenning, Marjolein I. A. Koetsier, Else N. Kop, John E. M. Körver, Astrid L. A. Kuijpers, Paula P. vanLümig, Johannes M. Mommers, Marcellus D. Njoo, Paul M. Ossenkoppele, Ron A. Tupker, M. Birgitte Visch, Lizelotte J. M. T. Weppner‐Parren, Elke M. G. J. deJong, Juul M. P. A. van denReek
Published 2022-09-01
Article